COVID-19 Vaccination in Patients with Myasthenia Gravis: A Single-Center Case Series

In this study, we report the safety of coronavirus disease 2019 (COVID-19) vaccine in patients with myasthenia gravis (MG). Patients who were vaccinated against COVID-19 were included. Demographics, clinical characteristics, medications, and vaccination information were collected. The main observati...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruan, Zhe, Tang, Yonglan, Li, Chunhong, Sun, Chao, Zhu, Ying, Li, Zhuyi, Chang, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537454/
https://www.ncbi.nlm.nih.gov/pubmed/34696220
http://dx.doi.org/10.3390/vaccines9101112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537454/
https://www.ncbi.nlm.nih.gov/pubmed/34696220
http://dx.doi.org/10.3390/vaccines9101112

Ejemplares similares